FGFR kinase inhibitors and pharmaceutical uses
US-11192890-B2 · Dec 7, 2021 · US
This page is not indexed by search engines while we improve data quality.
Guangzhou Inst Of Biomedicine And Health patents
Guangzhou Inst Of Biomedicine And Health holds 4 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 4 |
| Recent patents | 0 |
| First publication | Jun 27, 2019 |
| Latest publication | Dec 7, 2021 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Methods for treating cancer with rorgamma inhibitors
US-2021161837-A1 · Jun 3, 2021 · US
Fgfr kinase inhibitors and pharmaceutical uses
US-2020017491-A1 · Jan 16, 2020 · US
Methods for treating cancer with rorgamma inhibitors
US-2019192454-A1 · Jun 27, 2019 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
FGFR kinase inhibitors and pharmaceutical uses
US-11192890-B2 · Dec 7, 2021 · US
Methods for treating cancer with rorgamma inhibitors
US-2021161837-A1 · Jun 3, 2021 · US
Fgfr kinase inhibitors and pharmaceutical uses
US-2020017491-A1 · Jan 16, 2020 · US
Methods for treating cancer with rorgamma inhibitors
US-2019192454-A1 · Jun 27, 2019 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 4 |
| Chemistry & Metallurgy | 4 |